+1
with emphasis,
@whytee has nailed a strong summary and reason followers of the science:
"Right now though the market knows plans for commercialisation have been shelved and possibly concluded that NTcell "doesn't work." I think the second part is premature, since 3 of the first 4 patients do seem to have had a sustained durable response now over several years.
"I [too] belong to the group that believes [1] that embryological dopaminergic implants have been shown to work provided that the treatment is given before global damage is too severe, and [2] that side effects can be limited by not implanting an excessive number of dopaminergic cells and [3] the cells are implanted by distributing them uniformly along the length of the putamen."
I suspect the intention of going to market has not been shelved, just yet, even tho the application has had to be put on hold
I think we bang the "time" drum for as long as it takes as time seems to be the crucial fulcrum nearly everywhere i look including ncbi studies, the door remains widely open
- Forums
- ASX - By Stock
- research v. Phase II exam
+1 with emphasis, @whytee has nailed a strong summary and reason...
Featured News
Add 1AI (ASX) to my watchlist
|
|||||
Last
0.8¢ |
Change
0.001(14.3%) |
Mkt cap ! $13.49M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.8¢ | $34 | 4.285K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 8215316 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 1837858 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 8215316 | 0.007 |
11 | 5066749 | 0.006 |
8 | 6510009 | 0.005 |
4 | 4065000 | 0.004 |
2 | 4590000 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 1837858 | 8 |
0.009 | 1206691 | 9 |
0.010 | 2493145 | 4 |
0.011 | 1490400 | 3 |
0.012 | 363666 | 3 |
Last trade - 10.00am 04/09/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |